*By Carlo Versano*
Cannabis stocks continued their run Monday on renewed speculation that more big-name companies will add pot to their recreation portfolios.
The latest deal ー Canada's Nova Scotia Liquor inking an initial purchase order with pharmaceutical company Tilray ー sent shares of the latter up as much as 30 percent the day before its first earnings report as a public company. The stocks of Cronos and Canopy Growth, which earlier this month earned an investment from Corona-maker [Constellation Brands](https://cheddar.com/videos/corona-brewer-adds-cannabis-to-its-booze-business-in-4-billion-deal), rose too.
Sam Masucci, CEO and co-founder of ETF Managers Group, is trying to give investors a chance to capitalize on such gains.
He joined Cheddar Monday after ringing the opening bell at the NYSE to detail the ETFMG Alternative Harvest ETF, which launched in 2017. The fund tracks nearly 40 foreign and domestic companies that Masucci said may benefit from the production and sale of cannabis, both medicinal and recreational.
The ETF includes companies as varied as Scotts Miracle-Gro (which is developing hydroponics), Canopy Growth, and tobacco giant Phillip Morris.
Companies in Canada, where marijuana will be legalized for recreational sale in October, make up 40 percent of the basket of stocks, with 20 percent coming from the U.S.
While marijuana remains a Schedule I drug at the federal level in this U.S., legalization has gained serious momentum on a state basis.
Masucci said this fund is intended to capture some of that growing bipartisan acceptance and make a bet that medicinal marijuana will be legalized nationally.
"I think the federal government is starting to come around," he said.
A [market report](https://www.prnewswire.com/news-releases/data-shows-medical-cannabis-could-reach-usd-19-billion-in-sales-by-2027-807442325.html) released Monday predicts medicinal marijuana sales will hit $19 billion domestically within the next decade, with worldwide legal spending on cannabis reaching $57 billion.
That's the kind of upside exposure Masucci said he wanted to deliver to investors with the creation of the first "pure play" cannabis ETF.
For full interview [click here](https://cheddar.com/videos/legal-pot-business-booming).
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Scott Trench, host of the BiggerPockets Money Podcast, explores how recent rate cuts, high borrowing costs, and mortgage rates are reshaping U.S. real estate.
